Elite Pharmaceuticals Inc (ELTP) stock
ELTPOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through Q2 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 14/30
$0.25−0.00 (-1.37%)
Close on Oct 19, 2026Market cap $281.77MP/E 5.0Yield –
Elite Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Elite Pharmaceuticals's enterprise value was $231.16M on Oct 19, 2026, against $635.31M a year earlier. Over the last 5 years it ranged from $11.86M to $770.73M, with a median of $183.99M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $231.16M | -53.7% |
| 2025 | Dec 31, 2025 | $499.62M | -12.1% |
| 2024 | Dec 31, 2024 | $568.49M | +326.5% |
| 2023 | Dec 29, 2023 | $133.29M | +1023.7% |
| 2022 | Dec 30, 2022 | $11.86M | -54.1% |
| 2021 | Dec 31, 2021 | $25.85M | -43.4% |
| 2020 | Dec 31, 2020 | $45.69M | -36.8% |
| 2019 | Dec 31, 2019 | $72.30M | +38.8% |
| 2018 | Dec 31, 2018 | $52.08M | -17.1% |
| 2017 | Dec 29, 2017 | $62.79M | -48.3% |
| 2016 | Dec 30, 2016 | $121.46M | -55.4% |
| 2015 | Dec 31, 2015 | $272.14M | +110.9% |
| 2014 | Dec 31, 2014 | $129.02M | +120.2% |
| 2013 | Dec 31, 2013 | $58.60M | +111.0% |
| 2012 | Dec 31, 2012 | $27.77M | +68.3% |
| 2011 | Dec 30, 2011 | $16.50M | – |
See a number that looks wrong?